Related Experiment Video
Updated: May 8, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Intravascular imaging-guided percutaneous coronary intervention in patients with acute myocardial infarction and
Hyun Sung Joh1, Seung Hun Lee2, Jinhwan Jo3
1Department of Internal Medicine and Cardiovascular Center, Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
Insights
Intravascular imaging-guided percutaneous coronary intervention (PCI) significantly reduces major adverse cardiovascular events (MACE) in acute myocardial infarction (AMI) patients with cardiogenic shock. This approach lowers cardiac death risk compared to traditional angiography-guided PCI.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Imaging
Background:
- Limited clinical data exist on intravascular imaging-guided percutaneous coronary intervention (PCI) versus angiography-guided PCI in acute myocardial infarction (AMI) with cardiogenic shock.
- Evaluating this comparison is crucial for optimizing treatment strategies in high-risk cardiac patients.
Purpose of the Study:
- To assess the impact of intravascular imaging-guided PCI on clinical outcomes in patients experiencing AMI complicated by cardiogenic shock.
- To compare the efficacy of intravascular imaging versus angiography guidance for PCI in this specific patient cohort.
Main Methods:
- A retrospective analysis of 1833 patients with AMI and cardiogenic shock who underwent PCI from a nationwide pooled registry (KAMIR-NIH and KAMIR-V).
- Patients were divided into intravascular imaging-guided PCI (n=375) and angiography-guided PCI (n=1458) groups.
- The primary endpoint was major adverse cardiovascular events (MACE) at 1 year, including cardiac death, myocardial infarction, repeat revascularization, and stent thrombosis. Propensity score matching, inverse probability weighting, and Bayesian analysis were used for adjustment.
Main Results:
- Intravascular imaging-guided PCI was associated with a significantly lower risk of 1-year MACE compared to angiography-guided PCI (19.5% vs 28.2%; HR, 0.59).
- This reduction was primarily driven by a significantly lower risk of cardiac death in the imaging-guided group (13.7% vs 24.0%; adjusted HR, 0.53).
- Results remained consistent across various statistical adjustment methods, including propensity score matching and inverse probability weighting.
Conclusions:
- Intravascular imaging-guided PCI demonstrates a superior safety profile in patients with AMI and cardiogenic shock compared to angiography-guided PCI.
- The improved outcomes are mainly attributed to a reduction in cardiac mortality, highlighting the benefit of enhanced visualization during PCI in complex cases.
Introduction And Objectives:
There are no clinical data on the efficacy of intravascular imaging-guided percutaneous coronary intervention (PCI) compared with angiography-guided PCI in patients with acute myocardial infarction (AMI) and cardiogenic shock. The current study sought to evaluate the impact of intravascular imaging-guided PCI in patients with AMI and cardiogenic shock.
Methods:
Among a total of 28 732 patients from the nationwide pooled registry of KAMIR-NIH (November, 2011 to December, 2015) and KAMIR-V (January, 2016 to June, 2020), we selected a total of 1833 patients (6.4%) with AMI and cardiogenic shock who underwent PCI of the culprit vessel. The primary endpoint was major adverse cardiovascular events (MACE) at 1 year, a composite of cardiac death, myocardial infarction, repeat revascularization, and definite or probable stent thrombosis.
Results:
Among the study population, 375 patients (20.5%) underwent intravascular imaging-guided PCI and 1458 patients (79.5%) underwent angiography-guided PCI. Intravascular imaging-guided PCI was associated with a significantly lower risk of 1-year MACE than angiography-guided PCI (19.5% vs 28.2%; HR, 0.59; 95%CI, 0.45-0.77; P<.001), mainly driven by a lower risk of cardiac death (13.7% vs 24.0%; adjusted HR, 0.53; 95%CI, 0.39-0.72; P<.001). These results were consistent in propensity score matching (HR, 0.68; 95%CI, 0.46-0.99), inverse probability weighting (HR, 0.61; 95%CI, 0.45-0.83), and Bayesian analysis (Odds ratio, 0.66, 95% credible interval, 0.49-0.88).
Conclusions:
In AMI patients with cardiogenic shock, intravascular imaging-guided PCI was associated with a lower risk of MACE at 1-year than angiography-guided PCI, mainly driven by the lower risk of cardiac death.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization III: Left Heart Catheterization
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care

